Supporting this hypothesis, p53 mutation rate rises up to 15% in relapsed or previously treated NBs [22] and treatment of NB mouse xenografts with the p53 reactivating drug Nutlin-3 (Nut-3) leads to tumor shrinkage and impairment of metastasis [15]. Here, TP53 is linked to neoplasm.